MionC.M., HegstromR.M., BoenS.T., ScribnerB.H.: Substitution of sodium acetate for sodium bicarbonate in the bath fluid for hemodialysis.Trans. Amer. Soc. Artif. Int. Organs10: 110–113, 1964.
2.
LundquistF.: Production and utilization of free acetate in man.Nature193: 579–580, 1962.
3.
GonzalezF.M., PearsonJ.E., GarbusS.B., HolbertR.D.: On the effects of acetate during hemodialysis.Trans. Amer. Soc. Artif. Int. Organs20: 169–174, 1974.
4.
FrohlichE.D.: Vascular effects of the Krebs intermediate metabolites.American Journal of Physiology208: 149–153, 1965.
5.
NovelloA., KelschR.C., EasterlingR.E.: Acetate intolerance during hemodialysis.Clin. Nephrol.5: 29–32, 1976.
6.
PortF.K., EasterlingR.E.: Evaluation of acetate tolerance during highly efficient hemodialysis.Proc. Dial. Transplant Forum5: 128–130, 1975.
7.
GraefeU., MilutinovichJ., FolletteW., VizzoJ., BabbA., ScribnerB.: Less dialysis induced morbidity and vascular instability with bicarbonate in the dialysate.Ann. Int. Med.88: 332–336, 1977.
8.
BergstromJ.: Ultrafiltration without dialysis for removal of fluids and solutes in uremia.Clin. Nephrol.9: 156–164, 1978.
9.
KirkendolP.L., RobieN.W., GonzalezF.M., DeviaC.J.: Cardiac and vascular effects of infused sodium acetate.Trans. Amer. Soc. Artif. Int. Organs24: 714–717, 1978.
10.
TolchinN., RobertsJ., HayashiJ., LewisE.J.: Metabolic consequences of high mass-transfer hemodialysis.Kidney Int.11: 366–378, 1977.
11.
TsaltasT.T., FriedmanE.A.: Plasma lipid studies of uremic patients during hemodialysis.Amer. J. Clin. Nutr.21: 430–435, 1968.
12.
RichardsR., DonlingJ., FremanH., FeldmanC., WeinerM.: Acetate levels in human plasma.Proc. Dial. Transplant Forum6: 73–76, 1976.
13.
DavidsonD.W., MorinR.J., RorkeS.J., GuoL.S.S.: The role of acetate in dialysate for hemodialysis.Proc. 10th Annual Contractor's Conference. NIAMDD, HEW Publ. (NIH) 77–1442, p. 15–16, 1977.
14.
SavdieE., MahonyJ., StewartJ.: Effect of acetate on serum lipids in maintenance hemodialysis.Trans. Amer. Soc. Artif. Int. Organs23: 385–392, 1977.